Donald Trump, AP
July 9, 2019 08:08 AM EDTUpdated 08:20 AM
Pharma
FDA+

Fed­er­al judge scut­tles Trump's rule man­dat­ing drug prices in TV ads

Natalie Grover

Reporter

The Trump ad­min­is­tra­tion has en­dured a set­back af­ter a fed­er­al court over­turned a rul­ing — oblig­at­ing drug man­u­fac­tur­ers to dis­close the list price of their ther­a­pies …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times